(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1061)

FORM OF PROXY FOR THE ANNUAL GENERAL MEETING

TO BE HELD ON WEDNESDAY, 12 MAY 2021 (or any adjournment thereof)

I/We1 of being the registered holder(s) of2

shares (the "Shares") of HK$0.10 each in the share capital of

Essex Bio-Technology Limited (the "Company"), hereby appoint3 of

or failing him/her, the Chairman of the Meeting, as my/our proxy to attend and act for me/us and on my/our behalf at the annual general meeting (the "Meeting") of the Company to be held at Regus Conference Centre, 35th Floor, Central Plaza, 18 Harbour Road, Wanchai, Hong Kong on Wednesday, 12 May 2021 at 2:00 p.m. (or at any adjournment thereof) for the purpose of considering and, if thought fit, passing the resolutions as set out in the notice convening the Meeting (the "AGM Notice") and at the Meeting (or at any adjournment thereof) to vote for me/us and in my/our name(s) in respect of such resolutions as hereunder indicated, and, if no such indications is given, as my/our proxy thinks fit. My/our proxy will also be entitled to vote on any matter properly put to the Meeting in such manner as he/she thinks fit4.

ORDINARY RESOLUTIONS

For4

Against4

1.

To receive and consider the audited consolidated financial statements of the Company and its subsidiaries and the reports of the directors and auditors of the Company for the year ended 31 December 2020.

2.

(a)To re-elect Mr. Ngiam Mia Je Patrick as an executive director of the Company.

(b)To re-elect Mr. Fang Haizhou as an executive director of the Company.

(c)To re-elect Mr. Fung Chi Ying as an independent non-executive director of the Company.

(d)To re-elect Mr. Ngiam Hian Leng Malcolm as an executive director of the Company.

(e)To re-elect Ms. Yau Lai Man as an executive director of the Company.

(f)To authorise the board of directors of the Company to fix the remuneration of the directors.

3.

To re-appoint BDO Limited as the auditors of the Company and to authorise the board of directors to fix their remuneration.

4.

To consider and declare a final dividend of HK$0.05 per share of the Company for the year ended 31 December 2020.

5.

To grant a general and unconditional mandate to the directors of the Company to allot, issue or otherwise deal with shares of the Company and to make or grant offers, agreements, options and other rights which might require shares of the Company to be allotted or issued as set out in resolution numbered 5 of the AGM Notice.5

6.

To grant a general and unconditional mandate to the directors of the Company to exercise all the powers of the Company to repurchase shares of the Company as set out in resolution numbered 6 of the AGM Notice.5

7.

To add the number of shares repurchased by the Company under resolution numbered 6 to the mandate granted to the directors under resolution number 5, as set out in resolution numbered 7 of the AGM Notice.5

Signature6

Date

Notes:

  • 1. Full name(s) and address(es) must be inserted in BLOCK CAPITALS. The names of all joint registered holders should be stated.

  • 2. Please insert the number of shares registered in your name(s) to which this form of proxy relates. If no number is inserted, this form of proxy will be deemed to relate to all shares registered in your name(s).

  • 3. Please insert the full name and address of the proxy in BLOCK CAPITALS. IF NOT COMPLETED, THE CHAIRMAN OF THE MEETING WILL ACT AS YOUR PROXY.

  • 4. IMPORTANT: If you wish to vote for a resolution, tick in the box marked "For". If you wish to vote against a resolution, tick in the box marked "Against". If no direction is given, your proxy may vote or abstain as he/she thinks fit. Your proxy will also be entitled to vote at his/her discretion on any resolution properly put to the Meeting other than those referred to in the AGM Notice.

  • 5. The description of the resolution is by way of summary only. The full text of the resolution appears in the AGM Notice.

  • 6. This form of proxy must be signed by you or your attorney duly authorised in writing or, in the case of a corporation, must be either under its common seal or under the hand of an officer, attorney or other person duly authorised to sign the same.

  • 7. In order to be valid, this form of proxy together with the certified power of attorney (if any) or other authority (if any) under which it is signed, must be lodged with the branch share registrar of the Company in Hong Kong, Hong Kong Registrars Limited at 17M Floor, Hopewell Centre, 183 Queen's Road East, Hong Kong, not less than 48 hours before the time appointed for holding of the Meeting or the adjourned Meeting.

  • 8. In the case of joint registered holders of any share, any one of such persons may vote at the Meeting (or at any adjournment thereof), either in person or by proxy, in respect of such share as if he/she was solely entitled thereto; but if more than one of such joint registered holders are present at the Meeting (or at any adjournment thereof), the vote of the senior who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other joint registered holders. For this purpose, seniority shall be determined by the order in which the names stand in the register of members of the Company in respect of the joint holding.

  • 9. The proxy need not be a member of the Company but must attend the Meeting in person to represent you.

  • 10. Completion and return of this form will not preclude you from attending and voting in person at the Meeting (or at any adjournment thereof) if you so wish. If you attend and vote in person at the Meeting, the authority of your proxy will be revoked.

  • 11. ANY ALTERATION MADE TO THIS FORM OF PROXY MUST BE INITIALLED BY THE PERSON WHO SIGNS IT.

Attachments

  • Original document
  • Permalink

Disclaimer

Essex Bio-Technology Limited published this content on 25 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 March 2021 09:10:04 UTC.